Mission of Ersheng Biopharmaceutical Enterprise:
Help conquer cancer in the last mile, accelerate to run 100 meters!


Suzhou Ersheng Biomedical was established at the end of December 2021 and is located in the beautiful Suzhou Industrial Park Biomedical Industrial Park Biobay. The company has made many breakthrough original achievements in the fields of cancer vaccines based on whole cell antigen of cancer cells, cancer immunotherapy based on tumor antigen-specific T cells, peripheral blood tumor antigen-specific T cell detection, and mRNA vaccine delivery. The relevant core patents have been authorized domestically, and have entered countries and regions such as the United States, Japan, the European Union, Canada, Australia, South Korea, and Brazil. The company's mission is to help conquer the last mile of cancer and accelerate the 100 meter run. It focuses on the research and development of original innovative drugs, treatment methods, and detection technologies, hoping to develop into a technologically advanced enterprise in the field of cancer treatment and T cell therapy worldwide.

 read more
Drug delivery technology
Photovoltaic power generation is a technology that utilizes the photovoltaic effect at semiconductor interfaces to directly convert light energy into electrical energy. It mainly consists of three parts: solar panels (components), controllers, and inverters, with the main components composed of electronic components. After being connected in series and packaged for protection, solar cells can form large-area solar cell modules, which are combined with power controllers and other components to form photovoltaic power generation devices.
 read more
Drug development pipeline
A drug delivery system is a system that delivers drugs to drug targets, which can regulate the pharmacokinetics, efficacy, toxicity, immunogenicity, and other aspects of drugs Drug delivery systems can usually improve the stability of drugs; Reduce drug degradation; Reduce the toxic side effects of drugs; Improve the bioavailability of drugs; Maintain stable and effective blood drug concentrations; Avoiding fluctuations in blood drug concentration can also increase the drug concentration in the target area.
 read more
Drug delivery technology
Drug development pipeline
INVESTMENT HOT SPOT
MORE +
CORE TEAM
MORE +

  • Founder and Chairman

    Dr. Liu Mi

    Founder and Chairman: Dr. Liu Mi, graduated with a master's degree from the School of Pharmacy at Peking University in 2010, a doctoral degree from the Department of Pharmacy at ETH Z ü rich in Zurich in 2014, and a postdoctoral fellow in the Department of Immunology at Harvard Medical School in November 2014. Joined the Pharmacy Department of Suzhou University School of Pharmacy as a distinguished professor and doctoral supervisor in December 2018. It is mainly engaged in research on preventive and therapeutic cancer vaccines, therapeutic...

  • Co founders and CEO

    Dr. Wen Jun

    Co founder and CEO, Dr. Wen Jun, Bachelor's degree in Chemistry from Xiamen University, Master's degree in Pharmaceutical Chemistry from Peking University, PhD in Organic Chemistry from the University of Louisville in the United States, postdoctoral fellow at Professor Craig Crews Laboratory from Yale University, and EMBA from Guanghua School of Management at Peking University. Years of experience in research and management in the field of small molecule drug development...

NEWS CENTER
MORE +
　　
Hot new | Seventy years of development history of drug delivery technology

Drug delivery technology has made the development of many drug products possible, by enhancing the delivery of ...

2022-05-23 172
30 years of research achievements by American Academy of Sciences, revolutionary drug delivery technology to solve various clinical problem

Stanford University is the heart of Silicon Valley in the United States, with a strong entrepreneurial atmosph

2022-05-23 114
99.99% of mice prevent lung cancer, and the team led by Su Da and Liu Mi developed a nano vaccine prepared using cancer cells

Cancer vaccines are one of the main means of cancer immunotherapy and prevention Recently, Professor Liu Mi from the Department of Pharmacy at Suzhou University School of Pharmacy led a research team to publish a research paper online on Advanced Materia

2022-05-23 257
Suzhou University used cancer cell recombinant nano vaccine, and all 8 test mice achieved lung cancer prevention and recovery

Liu Mi is currently a distinguished professor in the Department of Pharmacy at the School of Pharmacy, Suzh

2022-05-23 215
NEWS CENTER
MORE +
STRATEGIC OBJECTIVE
Focusing on the research and development of innovative drugs, treatment methods, and detection technologies, we hope to develop into an advanced enterprise in the field of global cancer treatment and drug delivery.